Albuterol Sulfate Inhalation Solution
Product Images NDC 76204-010

12 FDA label images from Ritedose Pharmaceuticals, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Albuterol Sulfate Inhalation Solution (NDC 76204-010). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ritedose Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-01 (Image 01)

Image-01 (Image 01)
Chemical structure of Albuterol Sulfate showing the molecular components and arrangement including phenol groups, hydroxyl groups, a side chain with an isopropyl group, and sulfate ions.*
FDA Label Image

Image-02 (Image 02)

Image-02 (Image 02)
A line graph showing percent change over time from pre-dose up to 6 hours, comparing treatments with Albuterol Sulfate Inhalation Solution at 1.25 mg, 0.63 mg, and placebo. The y-axis represents percent change, and the x-axis represents hours from pre-dose. The graph presents data for three groups indicated in the legend: albuterol 1.25 mg, albuterol 0.63 mg, and placebo.*
FDA Label Image

Image-03 (Image 03)

Image-03 (Image 03)
A line graph depicting percent change over time in hours from pre-dose for three treatments: albuterol 1.25 mg, albuterol 0.63 mg, and placebo. The x-axis represents hours from pre-dose (0 to 6 hours), and the y-axis represents percent change. Three distinct lines correspond to each treatment, showing their respective percent changes over time.*
FDA Label Image

Image-04 (Image 04)

Image-04 (Image 04)
An instructional diagram showing a hand using a dropper to dispense liquid into a device, likely an inhalation medication chamber or nebulizer component, demonstrating the preparation step for Albuterol Sulfate Inhalation Solution.*
FDA Label Image

Image-05 (Image 05)

Image-05 (Image 05)
An instructional diagram showing a hand holding an Albuterol Sulfate Inhalation Solution inhaler with the mouthpiece removed, and another hand holding the mouthpiece cap, demonstrating the assembly or cleaning process for the inhaler device.*
FDA Label Image

Image-06 (Image 06)

Image-06 (Image 06)
Instructional illustrations showing a person using an inhalation device with a mouthpiece for Albuterol Sulfate Inhalation Solution. Figure 3 depicts the person inhaling through the mouthpiece, while Figure 4 shows the use of a spacer or holding chamber device during inhalation.*
FDA Label Image

0.63 mg 25 Count Brick Carton (07 063mg 25ct Brick Carton)

0.63 mg 25 Count Brick Carton (07 063mg 25ct Brick Carton)
Packaging label for Albuterol Inhalation Solution, USP 0.63 mg/3 mL by Ritedose Pharmaceuticals, LLC. The label shows product name, strength, dosage form as solution for inhalation, and a depiction of a single-dose vial. Includes storage conditions, active and inactive ingredients, usage instruction notices, barcodes, and NDC 76204-010-25. The carton contains 1 pouch of 25 x 3 mL vials and is marked Rx only.*
FDA Label Image

0.63 mg 25 Count Cards Carton (08 063mg 25ct Cards Carton)

0.63 mg 25 Count Cards Carton (08 063mg 25ct Cards Carton)
Packaging label for Albuterol Sulfate Inhalation Solution, USP 0.63 mg/3 mL by Ritedose Pharmaceuticals, LLC. The label displays dosage strength prominently in an orange oval and includes barcodes and a small illustration of a unit-dose vial. The product is indicated as a sterile unit-dose solution for inhalation, with carton contents of 5 pouches of 5 x 3 mL vials each.*
FDA Label Image

0.63 mg 30 Count Singles Carton (09 063mg 30ct Singles Carton)

0.63 mg 30 Count Singles Carton (09 063mg 30ct Singles Carton)
Packaging label for Albuterol Sulfate Inhalation Solution, USP 0.63 mg/3 mL by Ritedose Pharmaceuticals, LLC. The unfolded carton includes product name, strength, barcode, and indications for use as a sterile unit-dose vial solution for respiratory inhalation.*
FDA Label Image

1.25 mg 25 Count Brick Carton (10 125mg 25ct Brick Carton)

1.25 mg 25 Count Brick Carton (10 125mg 25ct Brick Carton)
Packaging label for Albuterol Sulfate Inhalation Solution USP, 1.25 mg/3 mL strength. The label includes product name, strength, dosage form as inhalation solution, and manufacturer Ritedose Pharmaceuticals, LLC. The label also features storage instructions, ingredients, usage caution, and a vial illustration on a white background with blue accents.*
FDA Label Image

1.25 mg 25 Count Cards Carton (11 125mg 25ct Cards Carton)

1.25 mg 25 Count Cards Carton (11 125mg 25ct Cards Carton)
The image shows a flat, unfolded carton label for Albuterol Inhalation Solution, USP, 1.25 mg/3 mL. The label includes the product name and strength prominently displayed, instructions for inhalation, and dosage form as a solution for respiratory inhalation. It also features the Ritedose Pharmaceuticals, LLC logo, barcode, and a vial illustration, indicating the packaging contains sterile unit-dose vials.*
FDA Label Image

1.25 mg 30 Count Singles Carton (12 125mg 30ct Singles Carton)

1.25 mg 30 Count Singles Carton (12 125mg 30ct Singles Carton)
Carton label for Albuterol Sulfate Inhalation Solution, USP 1.25 mg/3 mL by Ritedose Pharmaceuticals, LLC. The label specifies a sterile unit-dose vial solution for respiratory inhalation, with a visual depiction of a single unit-dose vial on two panels. The design includes dosage strength highlighted in blue and barcodes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.